Ivim Health Review

Ivim Health — Provider Profile

Overview

Ivim Health is a telehealth weight loss platform that separates itself from the async-only majority through a more hands-on clinical model: weekly provider check-ins and personalized dose adjustments throughout treatment. Where most compounded GLP-1 providers handle consultations asynchronously at the start and rarely follow up, Ivim builds ongoing provider contact into the program structure.

The pricing reflects that clinical model — patients pay a medication cost plus a recurring program fee ($74.99/month) that covers the provider support infrastructure. Total monthly cost lands around $150 for semaglutide and $224 for tirzepatide, which is competitive with mid-range compounded options given the clinical support included. The platform operates nationwide.

April 2026 context: Ivim uses compounded semaglutide and tirzepatide. These medications are not FDA-approved — they are prepared by state-licensed compounding pharmacies. FDA enforcement pressure on compounders is ongoing. Patients choosing any compounded pathway should weigh the regulatory environment against the cost gap with brand-name medications.

Pricing and protocol data sourced from this provider's public website, verified April 2026. Patient experience data from verified patient reports. We have no commercial relationship with this provider.

Medications Offered

• Compounded semaglutide injectable — Not FDA-approved; compounded through licensed 503A pharmacy partners
• Compounded tirzepatide injectable — Not FDA-approved; same pharmacy network

Pricing

Pricing last verified April 2026. Confirm current pricing directly with the provider before enrolling.

The program fee covers weekly provider check-ins and dose adjustment support. Patients comparing Ivim against lower-cost async-only providers should factor in the clinical support included — if you'd otherwise be paying separately for follow-up consultations, the program fee can represent good value.

States Served

Available nationwide.

Insurance

• Consultation and program: Included in program fee
• Medication: Compounded medications are not covered by insurance. Ivim is a cash-pay platform. Patients with insurance coverage for branded GLP-1s should compare total out-of-pocket cost before choosing a compounded pathway.

Consultation Process

Model: Initial async intake with ongoing synchronous provider check-ins.

1. Complete an online intake questionnaire covering health history, current medications, BMI, and weight loss goals
2. A provider reviews your submission and contacts you to confirm your program plan
3. If approved, compounded medication ships from licensed pharmacy partner
4. Weekly provider check-ins for dose review, side effect management, and titration decisions
5. Direct messaging available between scheduled check-ins

Pros

• Weekly provider check-ins — more clinical contact than async-only platforms
• Personalized dose adjustments based on ongoing provider review
• Both semaglutide and tirzepatide available
• Nationwide availability
• Structured program model rather than medication-only delivery

Cons

• Compounded medications only — no FDA-approved supply chain
• Active FDA enforcement pressure on compounders
• Program fee adds to total monthly cost (~$75/mo above medication price)
• Cash-pay only — no insurance pathway
• No in-person care option

Best For

Patients who want more clinical support than a standard async telehealth visit provides and are willing to pay a modest premium for weekly check-ins. Particularly suited to patients who are new to GLP-1 medications and expect to need guidance on titration, side effect management, or dose adjustments.

Not ideal for: Patients purely optimizing for minimum monthly cost (try Belle Health or Henry Meds), patients who want FDA-approved brand-name medications (try LillyDirect or Hims), or patients who need insurance navigation (try Zealthy).

Editorial Verdict

Ivim fills a gap in the compounded GLP-1 market: clinical support beyond the initial consultation. Most platforms in this price range are medication-delivery services with asynchronous intake and minimal follow-up. Ivim's weekly check-in model is more aligned with how weight loss medication is managed in traditional clinical settings.

At $74.99/month, the program fee materially raises the total versus bare-minimum providers. For patients confident managing titration on their own, the premium isn't justified. For patients who want a provider actively involved through dose increases, the weekly check-in structure is worth the difference.

The compounded medication caveat applies: these are not FDA-approved medications, and the regulatory environment is active. Ivim's clinical model doesn't change that fundamental characteristic.

Bottom line as of April 2026: Ivim is the compounded GLP-1 option for patients who want ongoing provider involvement baked into the program. Weekly check-ins are included — not an upgrade. Patients who don't need that level of support will pay more than necessary here.

Data Sources

Pricing and protocol information sourced from Ivim Health's official website (verified April 2026). Consultation process details sourced from provider onboarding flow documentation. Patient experience descriptions sourced from public patient reviews. Telehealth Ally has no affiliate or commercial relationship with this provider.

Related Content

• Best GLP-1 Weight Loss Programs 2026 — All providers ranked
• GLP-1 Compounding Pharmacies: What Patients Need to Know — Full regulatory context
• GLP-1 Cost & Insurance FAQ — What you'll actually pay